NASDAQ · Biotechnology

BBIO (BBIO) Stock

$76.57 -0.03% NASDAQ: BBIO Healthcare

Valuation

MetricValue
Price$76.57
Market Cap$15.00B
P/E Ratio-22.17
P/B Ratio-6.18
P/S Ratio22.47
EPS (TTM)$0.00
52-Week High$93.42
52-Week Low$48.78
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE31.67%
ROA-57.20%
ROCE-166.38%
Gross Margin-113.35%
Operating Margin-113.35%
Net Margin-100.64%
Debt/Equity-0.99
Current Ratio2.62

Annual Financials (USD)

Metric20212022202320242025
Revenue$70.0M$78.0M$9.0M$222.0M$502.0M
Operating Profit$-577.0M$-512.0M$-607.0M$-593.0M$-569.0M
Net Profit$-563.0M$-481.0M$-643.0M$-536.0M$-729.0M
EPS$-3.90$-3.35$-3.95$-2.88$-3.79
Op Margin-827.1%-659.6%-6528.8%-267.2%-113.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0B$623.0M$546.0M$919.0M$936.0M
Total Liabilities$1.9B$1.9B$1.9B$2.4B$3.0B
Cash$394.0M$377.0M$376.0M$681.0M$570.0M
Borrowings$1.7B$1.7B$1.7B$1.7B$2.7B

Latest News

FDA Accepts BMRN's sNDA Seeking Full Approval for Voxzogo Zacks · Jul 14, 2026 The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions MarketBeat · Jul 13, 2026 BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 10, 2026 How a Rival's Clinical Setback Sent BBIO Stock to a 52-Week High Zacks · Jul 10, 2026 Beyond The Breakout Drug: Is BridgeBio Pharma Stock A Buy On Its Next Act? Trefis · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-498.0M$-419.0M$-528.0M$-521.0M$-446.0M
Investing Cash Flow$-249.0M$447.0M$53.0M$60.0M$-26.0M
Financing Cash Flow$-343.0M$3.0M$2.0M$-43.0M$-60.0M
Net Cash Flow$38.0M$21.0M$-22.0M$289.0M$-111.0M
Free Cash Flow$-546.0M$-426.0M$-529.0M$-522.0M$-447.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.72
EV / EBITDA-28.80
FCF Yield-3.81%
Quick Ratio1.17
Interest Coverage-6.05
Return 1Y45.71%
Return 3Y150.98%
Return 5Y57.23%

Ownership

Insiders Held3.92%
Institutions Held102.01%
Institutions Float Held106.17%
Institutional HolderSharesReport Date
Blackrock Inc.14,207,7572026-03-31
Kohlberg Kravis Roberts & Co. L.P.13,260,9712026-03-31
Janus Henderson Group PLC13,179,0132026-03-31
Viking Global Investors, L.P.11,842,4342026-03-31
Farallon Capital Management LLC9,365,4632026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ASND $260.25 -1.06% 25.59 $16.16B 0.00%
BMRN $64.84 -0.60% 41.31 $12.53B 0.00%
EXEL $56.89 +4.12% 16.55 $14.30B 0.00%
IONS $59.88 -0.80% -41.80 $9.95B 0.00%
JAZZ $243.71 -2.78% 16.57 $15.31B 0.00%

About BBIO

BBIO is led by CEO Neil Kumar, employs 839 people, headquartered in Palo Alto, US, publicly traded since 2019.

BBIO stock trades at $76.57 with a market capitalization of $15.00B. The stock is valued at a price-to-earnings (P/E) ratio of -22.17, price-to-book of -6.18, price-to-sales of 22.47. Over the past 52 weeks the stock has ranged between $48.78 and $93.42, and currently trades 18.0% below its 52-week high.

On profitability, BBIO generates a return on equity (ROE) of 31.67% — well above the market average, a sign of a high-quality business, return on capital employed of -166.38%, an operating margin of -113.35%, a net profit margin of -100.64%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides